Research Comparison
Melatonin vs PT-141 (Bremelanotide)
A side-by-side research comparison of Melatonin and PT-141 (Bremelanotide) drawn from Cobalt Peptides' peptide database records.
Melatonin
Melatonin is an endogenous indoleamine hormone derived from tryptophan, primarily synthesised in the pineal gland. It plays a central role in regulating circadian rhythms, particularly the sleep–wake cycle, by responding to light–dark signals. In research settings, melatonin is widely used to study sleep regulation, chronobiology, antioxidant activity, and neuroendocrine function. Beyond its role in circadian signalling, melatonin exhibits potent antioxidant properties and influences mitochondrial function and cellular protection pathways.
PT-141 (Bremelanotide)
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist with selectivity for the MC3 and MC4 receptors in the central nervous system. Its described mechanism is central rather than vascular, which distinguishes it from compounds acting on peripheral blood flow such as PDE5 inhibitors. A licensed medicine containing bremelanotide exists in some jurisdictions and is prescribed by clinicians; the material supplied here is a research compound and is not that medicine.